Novartis
-
Watch "Fighting Malaria in Tanzania": Getting meds to malaria patients via grassroots education and more
2:48 AM Nov 20th
from Seesmic
-
We're honored: Scrip names our Executive Committee the Management Team of the Year.
5:30 AM Nov 19th
from web
-
We're pleased: Scrip recognizes our collaboration with Lonza as Best Partnership Alliance.
5:30 AM Nov 19th
from web
-
(US only) Frequent heartburn treatment is here: Novartis launches over-the-counter Prevacid®24HR.
11:29 PM Nov 11th
from web
-
@ Apologies for the delay in responding. Thanks for your understanding
7:39 AM Nov 7th
from Seesmic
in reply to VinumVine
-
@ Thx for your Q. For H1N1 vac., Novartis on track for US delivery Seasonal flu delivered
7:38 AM Nov 7th
from Seesmic
in reply to VinumVine
-
Celtura approval is key step toward replacing 50 year-old egg-based flu vaccine production w/ modern biotechnology
1:00 AM Nov 5th
from Seesmic
-
Clinical trials in more than 1850 individuals across all age groups show strong efficacy for Celtura
11:54 PM Nov 4th
from Seesmic
-
Novartis receives German regulatory approval for Celtura®, 1st adjuvanted cell culture-based A(H1N1) flu vaccine
10:34 PM Nov 4th
from Seesmic
-
Novartis opens $250M advanced technical R&D & manuf. facility in Changshu, furthering economic dev. of Jiangsu province
12:38 PM Nov 3rd
from web
-
Novartis Institute of BioMedical Research in Shanghai to research new meds to treat highly prevalent diseases in China
7:19 AM Nov 3rd
from Seesmic
-
Novartis to invest $1Bio to build largest pharmaceutical R&D institute in China
6:47 AM Nov 3rd
from Seesmic
-
Novartis is proud to be ranked one of the top 50 "world's most attractive employers."
8:41 AM Oct 30th
from web
-
New Novartis biological therapy approved in EU to treat patients with CAPS, a rare auto-inflammatory disease
11:42 PM Oct 27th
from mobile web
-
Novartis thanks the readers of MedAdNews for naming us "most admired pharmaceutical company"
9:21 AM Oct 23rd
from web
-
Novartis receives approval in EU for new 3-in-1 once-daily single pill to treat patients with high blood pressure
10:32 PM Oct 22nd
from web
-
Q3 Analyst webcast (slides/audio) starting now. Follow it here:
5:02 AM Oct 22nd
from web
-
Novartis delivers strong new product momentum and operational performance in first 9 mos. of 2009
10:13 PM Oct 21st
from web
-
We will announce our Q3 results tomorrow, Oct 22. Analyst webcast starts 2pm CET. More to come here
7:07 AM Oct 21st
from web
-
New Novartis Phase II study results announced for treatment of patients with chronic gout
4:58 AM Oct 20th
from Seesmic
|
- Name Novartis
- Location Switzerland
- Web http://novartis.com
- Bio Latest Novartis news and updates from Novartis Communications
|